Ain HoldingsAINPF 88 EBITDA Margin % is 6.11% as of Jan. 2026, which is 18% below its 10-year median of 7.48. GuruFocus rates AINPF with a GF Score™ of 88/100 and a GF Value™ of $55.38 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Ain Holdings ranks worse than 53.74% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ain Holdings's EBITDA for the
three
months ended in Jan. 2026 was $68 Mil. Ain Holdings's Revenue for the
three
months ended in Jan. 2026 was $1,117 Mil. Therefore, Ain Holdings's EBITDA margin for the quarter that ended in Jan. 2026 was 6.11%.
Ain Holdings (OTCPK:AINPF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ain Holdings EBITDA Margin % Related Terms
Ain Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ain Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ain Holdings EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Ain Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ain Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ain Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ain Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ain Holdings (AINPF) has a EBITDA Margin % of 6.11% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ain Holdings and its competitors. This is 18% below median its historical median of 7.48. Over the past decade, Ain Holdings' EBITDA Margin % has ranged from 6.82 to 9.50. According to the industry distribution chart, Ain Holdings ranks #359 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 53.7%.
Is Ain Holdings' EBITDA Margin % too high?
Ain Holdings' current EBITDA Margin % of 6.11% is 18% below median its 10-year median of 7.48. Over the past 10 years, this metric has ranged from a low of 6.82 to a high of 9.50. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Ain Holdings' value of 6.11% is 40.2% below this industry median. Based on the distribution chart, Ain Holdings ranks #359 out of 668 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Ain Holdings has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ain Holdings' EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Ain Holdings ranks #359 out of 668 companies for EBITDA Margin %. This places Ain Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.21. Ain Holdings' value of 6.11% is 40.2% below this benchmark. Historically, Ain Holdings' own EBITDA Margin % has ranged from 6.82 to 9.50 over the past decade. While the company's 10-year median is 7.48 vs. the industry median of 10.21, Ain Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ain Holdings's current EBITDA Margin % of 6.11% is 40.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ain Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ain Holdings's current EBITDA Margin % is 6.11%, which is 18% below median its own 10-year median of 7.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ain Holdings stock overvalued right now?
Based on GuruFocus' analysis, Ain Holdings (AINPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $55.38, compared to a current price of $36.86 — trading 33.4% below its estimated fair value. The current EBITDA Margin % is 6.11%, which is 18% below median its 10-year median of 7.48 and 40.2% below the Healthcare Providers & Services industry median of 10.21. Ain Holdings' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ain Holdings (AINPF), the current EBITDA Margin % is 6.11% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ain Holdings (AINPF) Overvalued in 2026?
Based on GuruFocus' analysis, Ain Holdings stock appears to be undervalued.
The current stock price of $36.86 is trading 33.4% below its estimated GF Value™ of $55.38.
GuruFocus considers Ain Holdings to be Significantly Undervalued.
Key valuation signals for AINPF:
EBITDA Margin %: 6.11% (18% below median its 10-year median of 7.48)
GF Value™: $55.38 vs. price of $36.86 (33.4% below fair value)
Industry Position: 40.2% below the Healthcare Providers & Services median (#359 of 668)
No single metric tells the full story. See the AINPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ain Holdings Inc's core business is the dispensing pharmacy business that includes preparing and dispensing drugs based on prescriptions. The company also generates revenue by selling generic drugs wholesale, pharmacy staffing services, and pharmacy consulting services. The company's additional business activity includes both urban and suburban drug and cosmetic stores. Ain operates the ainz & tuple brand that specifically targets female consumers in urban areas. The company also executes small real estate rental strategies.
88GF Score
Get the complete analysis for AINPF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINPF has been successfully added to your 
